Clinical analysis of 16 cases of total pelvic exenteration for patients with advanced or recurrent gynecologic cancer
SHAO Zhu-yan
WEN Qiang
YANG Zheng-yan
ZHU Jian-qing
ZHANG Ping
Abstract：Objective To evaluate the curative value of total pelvic exenteration in the treatment ot advanced or recurrent gynecologic malignant tumors and access the possible factors associated with outcome and survival.Methods We retrospectively analyzed the records of 16 patients who underwent pelvic exenteration for gynecologic malignancy between April 1995 and April 2012 in our hospital.Results The median duration of follow-up was 37.5 months (range:3～ 157) and the 5-year overall survival rate was 51.6％.Lymph node involvement retained a significant impact on OS and PFS.The other possible prognostic factors were tumor size,surgical margin status,etc.Infective pelvic effusion was the most common complication (37.5％).The severest complications were ileus (25.0％),ureteral anastomosis leak (18.8％) and intestinal anastomosis leaks (6.3％).Conclusion Though post-surgical complications frequently occur,pelvic exenteration is still a safe therapeutic option for advanced or recurrent gynecologic malignancy with high cure rate and little influence on quality of life.But this procedure should be considered in highly selected patients with no unresectable or metastatic diseases.
Keywords：pelvic exenterationuterine cervical cancercomplications
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 307-311 )